Altitude Life Science Ventures


Altitude Life Science Ventures is a venture capital firm that invests in early-stage life science companies. The firm focuses on markets with significant demand and growth potential, backing high-quality teams to build strong, defensible, and long-term businesses. Their investment scope includes therapeutics, diagnostics, gene editing, AI/machine learning therapeutics, medical devices, and more. Altitude leverages its expertise in intellectual property strategic planning to maximize and preserve the value of its portfolio companies.

Altitude Life Science Ventures

Altitude Life Science Ventures

1014 Market St. Suite 200, Kirkland, WA 98033


What We Do

Altitude provides IP strategic planning services, integrating fundamental activities of early-stage life science companies with the creation, development, and presentation of the company’s IP portfolio on a worldwide basis. This includes developing multiple levels of protection to complement the maturation of the company and development of the technology, confirm competitive advantages, preserve product opportunities, complement R&D activities, support business development, and maximize the value of the company’s technology.



Portfolio

Use of plant microbiome to improve yield in high stress environments

#Agriculture

Initial public offering October, 2019

#Biotechnology

Initial public offering February, 2019

#Biotechnology

Initial public offering September, 2018

#Biotechnology

Initial public offering August, 2021

#Biotechnology

Acquired by Pacific Biosciences (PACB) -- July, 2021

#Biotechnology


Key People

Managing Partner

Venture Partner

Venture Partner (UK)

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.